{"id":"https://openalex.org/W6993067735","doi":null,"title":"Nilvadipine in mild to moderate Alzheimer's disease: a randomised controlled trial.","display_name":"Nilvadipine in mild to moderate Alzheimer's disease: a randomised controlled trial.","alternate_titles":[],"publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W6993067735"},"language":"en","primary_location":{"id":"pmh:http://www.rian.ie/169671/","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2262/89298","pdf_url":null,"source":{"id":"https://openalex.org/S4306400033","display_name":"Arrow@dit (Dublin Institute of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210144925","host_organization_name":"Technological University Dublin","host_organization_lineage":["https://openalex.org/I4210144925"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal article"},"parent_works":[],"lineage":["https://openalex.org/W6993067735"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/2262/89298","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Coen, Robert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210154619","display_name":"St. James's Hospital","ror":"https://ror.org/04c6bry31","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I4210154619"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Coen, Robert","raw_affiliation_strings":["Mercer's Institute for Research on Ageing , St. James's Hospital , Dublin , Ireland,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mercer's Institute for Research on Ageing , St. James's Hospital , Dublin , Ireland,","institution_ids":["https://openalex.org/I4210154619"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kennelly, Sean","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]},{"id":"https://openalex.org/I2803035300","display_name":"Tallaght University Hospital","ror":"https://ror.org/01fvmtt37","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I2803035300"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Kennelly, Sean","raw_affiliation_strings":["Department of Age Related Healthcare , Tallaght Hospital , Dublin , Ireland,","Department of Medical Gerontology , Trinity College Dublin , Dublin , Ireland,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Age Related Healthcare , Tallaght Hospital , Dublin , Ireland,","institution_ids":["https://openalex.org/I2803035300"]},{"raw_affiliation_string":"Department of Medical Gerontology , Trinity College Dublin , Dublin , Ireland,","institution_ids":["https://openalex.org/I205274468"]}]},{"author_position":"last","author":{"id":null,"display_name":"Kenny, Rose","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Kenny, Rose","raw_affiliation_strings":["Department of Medical Gerontology , Trinity College Dublin (TCD) , Dublin , Ireland,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Gerontology , Trinity College Dublin (TCD) , Dublin , Ireland,","institution_ids":["https://openalex.org/I205274468"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.6431000232696533,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.6431000232696533,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.3555000126361847,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nilvadipine","display_name":"nilvadipine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cognitive-decline","display_name":"cognitive decline","score":0.8109999895095825},{"id":"https://openalex.org/keywords/dihydropyridine-calcium-channel-blockers","display_name":"dihydropyridine calcium channel blockers","score":0.9079999923706055},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/clinical-dementia-rating-sum-of-boxes","display_name":"CDR-SB","score":0.8050000071525574},{"id":"https://openalex.org/keywords/nincds-adrda-criteria","display_name":"NINCDS-ADRDA criteria","score":0.722000002861023},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.3160000145435333},{"id":"https://openalex.org/keywords/amyloid-fibril-formation","display_name":"amyloid fibril formation","score":0.6930000185966492},{"id":"https://openalex.org/keywords/regional-cerebral-blood-flow","display_name":"regional cerebral blood flow","score":0.9269999861717224},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.32899999618530273},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.421999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7457000017166138},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.5989999771118164},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4758000075817108},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.4569999873638153},{"id":"https://openalex.org/C2780906993","wikidata":"https://www.wikidata.org/wiki/Q5133756","display_name":"Clinical Dementia Rating","level":4,"score":0.45399999618530273},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45190000534057617},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.4383000135421753},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4320000112056732},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.4268999993801117},{"id":"https://openalex.org/C2984863031","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Cognitive decline","level":4,"score":0.4244999885559082},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.4140999913215637},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.40230000019073486},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.3968999981880188},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.3564999997615814},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3472999930381775},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32690000534057617},{"id":"https://openalex.org/C2779077818","wikidata":"https://www.wikidata.org/wiki/Q913257","display_name":"Mini\u2013Mental State Examination","level":4,"score":0.3174000084400177},{"id":"https://openalex.org/C2779281540","wikidata":"https://www.wikidata.org/wiki/Q5062122","display_name":"Central nervous system disease","level":2,"score":0.31200000643730164},{"id":"https://openalex.org/C2780566141","wikidata":"https://www.wikidata.org/wiki/Q3065932","display_name":"Cognitive disorder","level":4,"score":0.28630000352859497},{"id":"https://openalex.org/C6057870","wikidata":"https://www.wikidata.org/wiki/Q5141248","display_name":"Cognitive test","level":3,"score":0.28209999203681946},{"id":"https://openalex.org/C2777952318","wikidata":"https://www.wikidata.org/wiki/Q583908","display_name":"Vascular dementia","level":4,"score":0.2768000066280365},{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.2549999952316284}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:http://www.rian.ie/169671/","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2262/89298","pdf_url":null,"source":{"id":"https://openalex.org/S4306400033","display_name":"Arrow@dit (Dublin Institute of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210144925","host_organization_name":"Technological University Dublin","host_organization_lineage":["https://openalex.org/I4210144925"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal article"}],"best_oa_location":{"id":"pmh:http://www.rian.ie/169671/","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2262/89298","pdf_url":null,"source":{"id":"https://openalex.org/S4306400033","display_name":"Arrow@dit (Dublin Institute of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210144925","host_organization_name":"Technological University Dublin","host_organization_lineage":["https://openalex.org/I4210144925"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G6930100608","display_name":"A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer\u2019s disease","funder_award_id":"279093","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320325311","display_name":"University College London Hospitals NHS Foundation Trust","ror":"https://ror.org/042fqyp44"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W6993067735.pdf","grobid_xml":"https://content.openalex.org/works/W6993067735.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1912546114","https://openalex.org/W1953027527","https://openalex.org/W1964464904","https://openalex.org/W1971398866","https://openalex.org/W1991952617","https://openalex.org/W1992998861","https://openalex.org/W2006450819","https://openalex.org/W2040905269","https://openalex.org/W2041985085","https://openalex.org/W2063808031","https://openalex.org/W2065301205","https://openalex.org/W2074155495","https://openalex.org/W2074570179","https://openalex.org/W2076234773","https://openalex.org/W2076393535","https://openalex.org/W2090639741","https://openalex.org/W2101128742","https://openalex.org/W2104565625","https://openalex.org/W2145875145","https://openalex.org/W2150231759","https://openalex.org/W2156220037","https://openalex.org/W2171645631","https://openalex.org/W2211218327","https://openalex.org/W2505774393","https://openalex.org/W2510795385"],"related_works":["https://openalex.org/W2891955176","https://openalex.org/W2536313780","https://openalex.org/W2013969028","https://openalex.org/W2065301205","https://openalex.org/W2808043979","https://openalex.org/W3009893408","https://openalex.org/W1568866447","https://openalex.org/W2765580486","https://openalex.org/W2505774393","https://openalex.org/W2074155495"],"abstract_inverted_index":{"Background:":[0],"This":[1],"study":[2,107,431],"reports":[3],"the":[4,7,17,205,215,224,252,306,362,372,375,439,448,454],"findings":[5],"of":[6,19,156,168,180,230,262,283,291,361,401,425,429,447,450,453,456,465],"first":[8],"large-scale":[9],"Phase":[10],"III":[11],"investigator-driven":[12],"clinical":[13],"trial":[14,94,137],"to":[15,35,67,81,129,132,188,239,242,298,382,475],"slow":[16],"rate":[18],"cognitive":[20,75],"decline":[21,76],"in":[22,53,73,77,114,214,315,470],"Alzheimer":[23,63,83,170,272,477],"disease":[24,163,478],"with":[25,79,172,223,280],"a":[26,136,141,173,197,234,248,259,468,471],"dihydropyridine":[27],"(DHP)":[28],"calcium":[29],"channel":[30],"blocker,":[31],"nilvadipine.":[32],"Nilvadipine,":[33],"licensed":[34],"treat":[36],"hypertension,":[37],"reduces":[38],"amyloid":[39],"production,":[40],"increases":[41],"regional":[42],"cerebral":[43],"blood":[44],"flow,":[45],"and":[46,50,85,102,125,158,161,182,265,271,288,333,339,353,385,410,438],"has":[47],"demonstrated":[48],"anti-inflammatory":[49],"anti-tau":[51],"activity":[52],"preclinical":[54],"studies,":[55],"properties":[56],"that":[57,95,433,441],"could":[58],"have":[59],"disease-modifying":[60],"effects":[61],"for":[62,145,166,303,378],"disease.":[64],"We":[65],"aimed":[66],"determine":[68],"if":[69],"nilvadipine":[70,192,304,341,406,466],"was":[71,88,108,202,266,320,342,389],"effective":[72],"slowing":[74],"subjects":[78,434,443],"mild":[80,474],"moderate":[82,476],"disease.\\nMethods":[84],"findings:":[86],"NILVAD":[87],"an":[89],"18-month,":[90],"randomised,":[91],"placebo-controlled,":[92],"double-blind":[93],"randomised":[96,127],"participants":[97,120],"between":[98,277,391],"15":[99],"May":[100],"2013":[101],"13":[103,326,346],"April":[104],"2015.":[105],"The":[106,196,255,293,459],"conducted":[109],"at":[110,325,330,336,345,350,356],"23":[111],"academic":[112],"centres":[113],"nine":[115],"European":[116],"countries.":[117],"Of":[118],"577":[119],"screened,":[121],"511":[122],"were":[123,126,149,185,275,418,421,432,444],"eligible":[124,238],"(258":[128],"placebo,":[130],"253":[131],"nilvadipine).":[133],"Participants":[134,148,184],"took":[135],"treatment":[138,278,301,469],"capsule":[139],"once":[140],"day":[142],"after":[143],"breakfast":[144],"78":[146,337,357],"weeks.":[147,358],"aged":[150],">50":[151],"years,":[152],"meeting":[153],"National":[154],"Institute":[155],"Neurological":[157],"Communicative":[159],"Disorders":[160],"Stroke/Alzheimer\u2019s":[162],"Criteria":[164],"(NINCDS-ADRDA)":[165],"diagnosis":[167,287],"probable":[169],"disease,":[171],"Standardised":[174],"Mini-Mental":[175],"State":[176],"Examination":[177],"(SMMSE)":[178],"score":[179],"\u226512":[181],"<27.":[183],"randomly":[186],"assigned":[187],"8":[189],"mg":[190],"sustained-release":[191],"or":[193,374],"matched":[194],"placebo.":[195],"priori":[198],"defined":[199],"primary":[200,243,295],"outcome":[201,308],"progression":[203],"on":[204,247,251,305,318,340,371,394,397,405],"Alzheimer's":[206],"Disease":[207],"Assessment":[208,377],"Scale":[209,228],"Cognitive":[210],"Subscale-12":[211],"(ADAS-Cog":[212],"12)":[213],"modified":[216],"intention-to-treat":[217],"(mITT)":[218],"population":[219,472],"(n":[220],"=":[221,310],"498),":[222],"Clinical":[225],"Dementia":[226],"Rating":[227],"sum":[229],"boxes":[231],"(CDR-sb)":[232],"as":[233,467],"gated":[235],"co-primary":[236,307],"outcome,":[237],"be":[240,383],"promoted":[241],"end":[244],"point":[245],"conditional":[246],"significant":[249],"effect":[250],"ADAS-Cog":[253,316],"12.":[254],"analysis":[256],"set":[257],"had":[258,435],"mean":[260,282,289],"age":[261],"73":[263],"years":[264,285],"62%":[267],"female.":[268],"Baseline":[269],"demographic":[270],"disease\u2013specific":[273],"characteristics":[274],"similar":[276,390],"groups,":[279],"reported":[281],"1.7":[284],"since":[286],"SMMSE":[290],"20.4.":[292],"prespecified":[294],"analyses":[296,360],"failed":[297],"show":[299],"any":[300],"benefit":[302,464],"(p":[309],"0.465).":[311],"Decline":[312],"from":[313],"baseline":[314],"12":[317],"placebo":[319],"0.79":[321],"(95%":[322],"CI,":[323],"\u22120.07\u20131.64)":[324],"weeks,":[327,332,347,352],"6.41":[328],"(5.33\u20137.49)":[329],"52":[331,351],"9.63":[334],"(8.33\u201310.93)":[335],"weeks":[338],"0.88":[343],"(0.02\u20131.74)":[344],"5.75":[348],"(4.66\u20136.85)":[349],"9.41":[354],"(8.09\u201310.73)":[355],"Exploratory":[359],"planned":[363],"secondary":[364],"outcomes":[365],"showed":[366],"no":[367],"substantial":[368],"effects,":[369],"including":[370],"CDR-sb":[373],"Disability":[376],"Dementia.":[379],"Nilvadipine":[380],"appeared":[381],"safe":[384],"well":[386],"tolerated.":[387],"Mortality":[388],"groups":[392],"(3":[393],"nilvadipine,":[395],"4":[396],"placebo);":[398],"higher":[399],"counts":[400],"adverse":[402,412],"events":[403,413],"(AEs)":[404],"(1,129":[407],"versus":[408,416],"1,030),":[409],"serious":[411],"(SAEs;":[414],"146":[415],"101),":[417],"observed.":[419],"There":[420],"14":[422],"withdrawals":[423],"because":[424,446],"AEs.":[426],"Major":[427],"limitations":[428],"this":[430],"established":[436],"dementia":[437],"likelihood":[440],"non-Alzheimer":[442],"included":[445],"lack":[449],"biomarker":[451],"confirmation":[452],"presence":[455],"brain":[457],"amyloid.\\nConclusions:":[458],"results":[460],"do":[461],"not":[462],"suggest":[463],"spanning":[473]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W6993067735","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-10-10T00:00:00"}
